380 related articles for article (PubMed ID: 31698143)
21. Contribution of DHA diols (19,20-DHDP) produced by cytochrome P450s and soluble epoxide hydrolase to the beneficial effects of DHA supplementation in the brains of rotenone-induced rat models of Parkinson's disease.
Oguro A; Ishihara Y; Siswanto FM; Yamazaki T; Ishida A; Imaishi H; Imaoka S
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Feb; 1866(2):158858. PubMed ID: 33279658
[TBL] [Abstract][Full Text] [Related]
22. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A
Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863
[TBL] [Abstract][Full Text] [Related]
23. The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.
Maayah ZH; Abdelhamid G; Elshenawy OH; El-Sherbeni AA; Althurwi HN; McGinn E; Dawood D; Alammari AH; El-Kadi AOS
Cardiovasc Toxicol; 2018 Jun; 18(3):268-283. PubMed ID: 29196978
[TBL] [Abstract][Full Text] [Related]
24. Soluble epoxide hydrolase: A potential target for metabolic diseases.
He J; Wang C; Zhu Y; Ai D
J Diabetes; 2016 May; 8(3):305-13. PubMed ID: 26621325
[TBL] [Abstract][Full Text] [Related]
25. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
Yu Z; Xu F; Huse LM; Morisseau C; Draper AJ; Newman JW; Parker C; Graham L; Engler MM; Hammock BD; Zeldin DC; Kroetz DL
Circ Res; 2000 Nov; 87(11):992-8. PubMed ID: 11090543
[TBL] [Abstract][Full Text] [Related]
26. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
[TBL] [Abstract][Full Text] [Related]
27. Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism.
Marowsky A; Burgener J; Falck JR; Fritschy JM; Arand M
Neuroscience; 2009 Oct; 163(2):646-61. PubMed ID: 19540314
[TBL] [Abstract][Full Text] [Related]
28. Measurement of soluble epoxide hydrolase (sEH) activity.
Morisseau C; Hammock BD
Curr Protoc Toxicol; 2007; Chapter 4():Unit 4.23. PubMed ID: 23045145
[TBL] [Abstract][Full Text] [Related]
29. Epoxy fatty acids and inhibition of the soluble epoxide hydrolase selectively modulate GABA mediated neurotransmission to delay onset of seizures.
Inceoglu B; Zolkowska D; Yoo HJ; Wagner KM; Yang J; Hackett E; Hwang SH; Lee KS; Rogawski MA; Morisseau C; Hammock BD
PLoS One; 2013; 8(12):e80922. PubMed ID: 24349022
[TBL] [Abstract][Full Text] [Related]
30. Expression and characterization of an epoxide hydrolase from Anopheles gambiae with high activity on epoxy fatty acids.
Xu J; Morisseau C; Hammock BD
Insect Biochem Mol Biol; 2014 Nov; 54():42-52. PubMed ID: 25173592
[TBL] [Abstract][Full Text] [Related]
31. Role of cytochrome P450-derived, polyunsaturated fatty acid mediators in diabetes and the metabolic syndrome.
Dos Santos LRB; Fleming I
Prostaglandins Other Lipid Mediat; 2020 Jun; 148():106407. PubMed ID: 31899373
[TBL] [Abstract][Full Text] [Related]
32. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
[TBL] [Abstract][Full Text] [Related]
33. Soluble epoxide hydrolase: a novel target for the treatment of hypertension.
Fang X
Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):67-72. PubMed ID: 18221075
[TBL] [Abstract][Full Text] [Related]
34. Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy.
Chen G; Xu R; Wang Y; Wang P; Zhao G; Xu X; Gruzdev A; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E563-75. PubMed ID: 22739108
[TBL] [Abstract][Full Text] [Related]
35. Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs.
Zhang Y; Gao L; Yao B; Huang S; Zhang Y; Liu J; Liu Z; Wang X
Life Sci; 2022 Dec; 310():121122. PubMed ID: 36309225
[TBL] [Abstract][Full Text] [Related]
36. The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling.
Wagner K; Vito S; Inceoglu B; Hammock BD
Prostaglandins Other Lipid Mediat; 2014 Oct; 113-115():2-12. PubMed ID: 25240260
[TBL] [Abstract][Full Text] [Related]
37. Epoxygenated fatty acids and soluble epoxide hydrolase inhibition: novel mediators of pain reduction.
Wagner K; Inceoglu B; Gill SS; Hammock BD
J Agric Food Chem; 2011 Apr; 59(7):2816-24. PubMed ID: 20958046
[TBL] [Abstract][Full Text] [Related]
38. Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.
Napimoga MH; Rocha EP; Trindade-da-Silva CA; Demasi APD; Martinez EF; Macedo CG; Abdalla HB; Bettaieb A; Haj FG; Clemente-Napimoga JT; Inceoglu B; Hammock BD
J Periodontal Res; 2018 Oct; 53(5):743-749. PubMed ID: 29851077
[TBL] [Abstract][Full Text] [Related]
39. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response.
Nayeem MA; Geldenhuys WJ; Hanif A
Adv Pharmacol; 2023; 97():37-131. PubMed ID: 37236764
[TBL] [Abstract][Full Text] [Related]
40. Beyond detoxification: a role for mouse mEH in the hepatic metabolism of endogenous lipids.
Marowsky A; Meyer I; Erismann-Ebner K; Pellegrini G; Mule N; Arand M
Arch Toxicol; 2017 Nov; 91(11):3571-3585. PubMed ID: 28975360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
